Some experts performed relevant meta-analyses of the analysis and concluded that the Rad51 G172T polymorphism may play a protective role in the development of head and neck cancer, but no significant correlation was found between the Rad51 G172T polymorphism and breast and ovarian cancer (84). The gene discussed is RAD51; the disease is ovarian carcinoma.